Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftriaxone + Doxycycline vs BPG + Doxycycline for Early Syphilis in PLWH
NCT05980871Phase 4Terminated
- Sponsor
- National Taiwan University Hospital
- Start
- Mar 2023
- Primary completion
- Jul 2025
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of ceftriaxone in syphilis, sponsored by National Taiwan University Hospital. Started Mar 2023; status: terminated.
02
Drugs
ceftriaxone
03
Conditions
syphilis
Beyond the preview
Go deeper on NCT05980871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05980871.